Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer

Conditions:   Colorectal Neoplasms;   Solid Tumors
Interventions:   Drug: Hu5F9-G4;   Drug: Cetuximab
Sponsor:   Forty Seven, Inc.
Not yet recruiting - verified November 2016

http://ift.tt/2fgN8oO